“With the full U.S. availability of TECNIS PureSee IOL, we are expanding access to an important extended depth of focus option that reflects our commitment to innovation, visual quality, and patient ...

Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...

Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...

ClearSight is now offering the Tecnis Odyssey Lens, a next-generation intraocular lens (IOL) designed for patients undergoing cataract surgery or Custom Lens Replacement. This advanced lens technology ...

Johnson & Johnson Vision (JNJ) has received approval in the US for TECNIS Synergy and TECNIS Synergy Toric II IOLs. In Canada, it received approval for TECNIS Synergy Toric II IOLs. This ...

Please provide your email address to receive an email when new articles are posted on . The Tecnis Synergy and Tecnis Synergy Toric II IOLs are now available for patients undergoing cataract surgery ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — In this Healio Video Perspective from the ASCRS meeting, Brian Schwam, MD, discusses a trio of ...

SANTA ANA, Calif., Feb. 2, 2021 /PRNewswire/ -- Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S.

Johnson & Johnson is expanding the US roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is an extended depth of focus (EDOF) lens designed to ...